Patent · US Active

Assessment of risk for colorectal cancer

US8153369B2 · kind B2 · utility

0Cited by
0References
5Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 5, 2007
Grant dateApr 10, 2012
Priority date
Expiry dateSep 25, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/136
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed is a method for identifying an individual who has an altered risk for developing colorectal cancer comprising detecting a single nucleotide polymorphism (SNP).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.